Used in neuroscience research to quantify levels of β-amyloid 42 peptide in biological samples such as cell culture supernatants, cerebrospinal fluid, and brain tissue extracts. This kit is essential for studying Alzheimer’s disease pathology, as Aβ-42 is a major component of amyloid plaques found in the brains of affected individuals. Enables researchers to assess amyloid burden, evaluate efficacy of therapeutic compounds targeting amyloid production or clearance, and monitor changes in Aβ-42 levels in experimental models. Widely applied in preclinical drug development and biomarker studies.